Design Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Design Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Design Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $262M, a 12.8% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$262M	-$38.2M	-12.8%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$270M	-$42M	-13.5%	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$279M	-$46M	-14.2%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$290M	-$51.5M	-15.1%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$300M	-$54.7M	-15.4%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$312M	-$56.3M	-15.3%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$325M	-$54.1M	-14.3%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$341M	-$49.4M	-12.7%	Dec 31, 2022	10-K	2024-03-19
Q3 2022	$355M	-$45.8M	-11.4%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$368M	-$37.2M	-9.19%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$379M	-$33.1M	-8.03%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$391M	+$354M	+970%	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$400M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$405M			Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$412M			Mar 31, 2021	10-Q	2021-05-10
Q4 2020	$36.5M			Dec 31, 2020	10-K	2022-03-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.